Ophthalmology

REACH is an experienced thought leader in the ophthalmology space. Our team has conducted research across many ophthalmological diseases, both rare and non-rare.

DISEASES WE COVER

Ophthalmology has evolved from an often overlooked therapeutic area dominated by anti-VEGF injections and surgical treatment to an active pipeline of novel potentially disease-modifying therapies. Current ophthalmological dynamics the REACH team is tracking include:

  • The imminent shortage of ophthalmologists to perform intravitreal injections
  • Additional approvals of complement targeted therapies for Geographic Atrophy
  • Novel approaches across ophthalmology such as stem cell therapy, gene therapy and neuroprotection
See our rare ophthalmology solutions

Search Ophthalmology diseases we cover



Browse contacts:
1 2 3 13

Schedule an ophthalmology demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare ophthalmology market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare ophthalmological conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any ophthalmology disease allow easy comparison across the ophthalmology therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for ophthalmologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us